Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

The impact of biologics and biosimilars

Where Stock Exchange Tower
800 Square Victoria, Suite 3700
Montréal, QC
H4Z 1E9
Get directions


Montréal InVivo and Fasken Martineau are pleased to invite you to a breakfast seminar on biologics and biosimilars. Join us and learn more about the impact of these types of drugs on the life sciences business environment from an intellectual property law and regulatory perspective.


Some of the topics the speakers will address include:

  • Biologics litigation: proceedings before the Federal Court of Canada between innovators and generics under the Patented Medicines (Notice of Compliance) Regulations and the Patent Act;
Challenges and issues concerning biologic drug patents;
  • Latest developments on biologic and biosimilar product reimbursements in Québec

    We look forward to welcoming you !
    This training session is an invitation only event. For all queries, please contact Virginie Razungles at 514 397 5182 or